FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3187675304> ?p ?o ?g. }

• W3187675304 endingPage "1205" @default.
• W3187675304 startingPage "1205" @default.
• W3187675304 abstract "Cancer stem-like cells (CSLCs) have been considered to be one of the main problems in tumor treatment owing to high tumorigenicity and chemotherapy resistance. In this study, we synthesized a novel mitochondria-target derivate, triphentlphosphonium-resveratrol (TPP-Res), and simultaneously encapsulated it with doxorubicin (Dox) in pH-sensitive liposomes (PSL (Dox/TPP-Res)), to reverse chemotherapeutic resistance of CSLCs. PSL (Dox/TPP-Res) was approximately 165 nm in size with high encapsulation efficiency for both Dox and TPP-Res. Cytotoxicity assay showed that the optimal synergistic effect was the drug ratio of 1:1 for TPP-Res and Dox. Cellular uptake and intracellular trafficking assay indicated that PSL (Dox/TPP-Res) could release drugs in acidic endosomes, followed by mitochondrial targeting of TPP-Res and nucleus transports for Dox. The mechanisms for reversing the resistance in CSLCs were mainly attributed to a synergistic effect for reduction of mitochondrial membrane potential, activation of caspase cascade reaction, reduction of ATP level and suppression of the Wnt/β-catenin pathway. Further, in vivo assay results demonstrated that the constructed liposomes could efficiently accumulate in the tumor region and possess excellent antineoplastic activity in an orthotopic xenograft tumor model with no evident systemic toxicity. The above experimental results determined that PSL (Dox/TPP-Res) provides a new method for the treatment of heterogenecity tumors." @default.
• W3187675304 created "2021-08-16" @default.
• W3187675304 creator A5003322678 @default.
• W3187675304 creator A5006226605 @default.
• W3187675304 creator A5009353607 @default.
• W3187675304 creator A5043131666 @default.
• W3187675304 creator A5048226529 @default.
• W3187675304 creator A5073975019 @default.
• W3187675304 date "2021-08-05" @default.
• W3187675304 modified "2023-09-26" @default.
• W3187675304 title "Construction of Hierarchical-Targeting pH-Sensitive Liposomes to Reverse Chemotherapeutic Resistance of Cancer Stem-like Cells" @default.
• W3187675304 cites W1265966323 @default.
• W3187675304 cites W1567719786 @default.
• W3187675304 cites W1963983068 @default.
• W3187675304 cites W1979108272 @default.
• W3187675304 cites W1979440527 @default.
• W3187675304 cites W1980714336 @default.
• W3187675304 cites W1981599964 @default.
• W3187675304 cites W1983364027 @default.
• W3187675304 cites W1987283439 @default.
• W3187675304 cites W1997849655 @default.
• W3187675304 cites W1998728654 @default.
• W3187675304 cites W1999356404 @default.
• W3187675304 cites W2003402838 @default.
• W3187675304 cites W2028431915 @default.
• W3187675304 cites W2030778924 @default.
• W3187675304 cites W2037998901 @default.
• W3187675304 cites W2042159082 @default.
• W3187675304 cites W2050110236 @default.
• W3187675304 cites W2057472478 @default.
• W3187675304 cites W2058494666 @default.
• W3187675304 cites W2068973847 @default.
• W3187675304 cites W2070554086 @default.
• W3187675304 cites W2078053367 @default.
• W3187675304 cites W2079641266 @default.
• W3187675304 cites W2082823320 @default.
• W3187675304 cites W2094285248 @default.
• W3187675304 cites W2107400278 @default.
• W3187675304 cites W2115833310 @default.
• W3187675304 cites W2125210489 @default.
• W3187675304 cites W2135925682 @default.
• W3187675304 cites W2139544398 @default.
• W3187675304 cites W2151089147 @default.
• W3187675304 cites W2162784293 @default.
• W3187675304 cites W2163572089 @default.
• W3187675304 cites W2293091085 @default.
• W3187675304 cites W2514833799 @default.
• W3187675304 cites W2597266846 @default.
• W3187675304 cites W2734768350 @default.
• W3187675304 cites W2789724716 @default.
• W3187675304 cites W2807135845 @default.
• W3187675304 cites W2907262475 @default.
• W3187675304 cites W2913475012 @default.
• W3187675304 cites W3120782871 @default.
• W3187675304 doi "https://doi.org/10.3390/pharmaceutics13081205" @default.
• W3187675304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8399523" @default.
• W3187675304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34452166" @default.
• W3187675304 hasPublicationYear "2021" @default.
• W3187675304 type Work @default.
• W3187675304 sameAs 3187675304 @default.
• W3187675304 citedByCount "6" @default.
• W3187675304 countsByYear W31876753042022 @default.
• W3187675304 countsByYear W31876753042023 @default.
• W3187675304 crossrefType "journal-article" @default.
• W3187675304 hasAuthorship W3187675304A5003322678 @default.
• W3187675304 hasAuthorship W3187675304A5006226605 @default.
• W3187675304 hasAuthorship W3187675304A5009353607 @default.
• W3187675304 hasAuthorship W3187675304A5043131666 @default.
• W3187675304 hasAuthorship W3187675304A5048226529 @default.
• W3187675304 hasAuthorship W3187675304A5073975019 @default.
• W3187675304 hasBestOaLocation W31876753041 @default.
• W3187675304 hasConcept C109316439 @default.
• W3187675304 hasConcept C121608353 @default.
• W3187675304 hasConcept C133936738 @default.
• W3187675304 hasConcept C153911025 @default.
• W3187675304 hasConcept C185154212 @default.
• W3187675304 hasConcept C185592680 @default.
• W3187675304 hasConcept C190283241 @default.
• W3187675304 hasConcept C202751555 @default.
• W3187675304 hasConcept C2776694085 @default.
• W3187675304 hasConcept C2781303535 @default.
• W3187675304 hasConcept C501593827 @default.
• W3187675304 hasConcept C502942594 @default.
• W3187675304 hasConcept C54355233 @default.
• W3187675304 hasConcept C55493867 @default.
• W3187675304 hasConcept C86803240 @default.
• W3187675304 hasConcept C96232424 @default.
• W3187675304 hasConcept C98274493 @default.
• W3187675304 hasConceptScore W3187675304C109316439 @default.
• W3187675304 hasConceptScore W3187675304C121608353 @default.
• W3187675304 hasConceptScore W3187675304C133936738 @default.
• W3187675304 hasConceptScore W3187675304C153911025 @default.
• W3187675304 hasConceptScore W3187675304C185154212 @default.
• W3187675304 hasConceptScore W3187675304C185592680 @default.
• W3187675304 hasConceptScore W3187675304C190283241 @default.
• W3187675304 hasConceptScore W3187675304C202751555 @default.
• W3187675304 hasConceptScore W3187675304C2776694085 @default.
• W3187675304 hasConceptScore W3187675304C2781303535 @default.

• next